Joel Gish
Physician Assistant · Chester, NYNPI 1306813688
Payments from drug & device makers
Across 196 payments — averaging $19.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$540
- AbbVie$540
- AstraZeneca$539
- Novo Nordisk$481
- Pfizer$333
- GSK$310
- plus $1K from 21 others
What the payments were for
- Food & beverage$3,838100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 38 | $540 |
| AbbVie | 24 | $540 |
| AstraZeneca | 23 | $539 |
| Novo Nordisk | 25 | $481 |
| Pfizer | 19 | $333 |
| GSK | 15 | $310 |
| Abbott | 13 | $227 |
| Exact Sciences | 7 | $169 |
| Axsome Therapeutics, Inc. | 4 | $79 |
| Sanofi-aventis U.S. LLC | 3 | $73 |
| Bayer | 3 | $67 |
| LNHC, Inc | 1 | $65 |
| Otsuka America Pharmaceutical, Inc. | 2 | $53 |
| Merck | 3 | $52 |
| Boehringer Ingelheim | 3 | $43 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $39 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $30 |
| Lundbeck LLC | 1 | $28 |
| Astellas Pharma US Inc | 1 | $27 |
| Inspire Medical Systems, Inc. | 1 | $21 |
| Renalytix AI, Inc. | 1 | $20 |
| Amgen | 1 | $19 |
| Collegium Pharmaceutical, Inc. | 1 | $18 |
| Vanda Pharmaceuticals Inc. | 1 | $17 |
| Phathom Pharmaceuticals, Inc. | 1 | $17 |
| Viiv Healthcare Company | 1 | $16 |
| Bavarian Nordic A/s | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,838 in reported general payments places this provider in the 90th percentile of 11,358 physician assistant providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 17 | $19,562 |
| LinzessLinaclotide | 13 | $8,749 |
| Gabapentin | 56 | $1,282 |
| Rosuvastatin Calcium | 31 | $827 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 29 | $812 |
| Quetiapine Fumarate | 18 | $582 |
| Potassium Chloride | 13 | $524 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 36 | $503 |
| Metoprolol Succinate | 37 | $495 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 24 | $480 |
| Alprazolam | 32 | $459 |
| CefuroximeCefuroxime Axetil | 16 | $391 |
| Oxycodone Hcl | 18 | $374 |
| Tramadol Hcl | 37 | $308 |
| Trazodone Hcl | 41 | $293 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $333 | $19,56217 claims |
| AbbVieLinzess | $540 | $8,74913 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 11,358 physician assistant providers in New York.
Other physician assistant in Chester
- Henry YuBronx$1M
- Michael AsbachAmherst$962K
- Janelle BunceJamestown$565K
- Kristyl Cuenca-SiskoNew York$478K
- Melissa WhiteGarden City$320K
- Lawrence HermanHolbrook$315K
- Kaitlyn NelsonBrooklyn$289K
- Sari KatzGarden City$271K
- Julius NwosuBronx$256K
- Cameron KiserNew York$225K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.